Want to track RCUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arcus Biosciences, Inc. (RCUS) Statistics
Valuation metrics
Market Cap 2.78B
Enterprise value 2.3B
Trailing P/E (ttm) -4.72
Forward P/E -
PEG ratio 0.23
Price/Sales (ttm) 19.93
Price/Book (mrq) 5.04
Enterprise Value/Revenue 19.62
Enterprise Value/EBITDA -5.48
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.74M
Average volume (90 days) 1.69M
Price summary
52-Week low 17.43
52-Week high 31.74
Beta -
50-Day moving average 24.46
200-Day moving average 26.13
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.86%
Operating margin -4.15%
Operational effectiveness
Return on assets -0.49%
Return on equity -0.88%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.93
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.58
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.57
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 3.82%
Book value per share (mrq) 3.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
